PF-Atlas › Clinical Trials › NCT03797677
MN4000 for Treatment of CF and MND Patients in the Home Setting
MN 4000 · Not specified
Registry ID
NCT03797677
Phase
Not specified
Status
Completed
Drug / intervention
MN 4000
Sponsor
Hill-Rom
Start
2017-03-09
Enrollment
10
Locations
1
About this trial
The study was a non-randomized open label pilot study. It was an observational design conducted at one (1) site in the US. All enrolled subjects received treatment with the MN4000. This pilot study evaluated subject satisfaction with the therapy and adherence to the therapy during the 90-day treatment period, and also collected clinical outcome data. Outcomes were assessed before, during and after the MN4000 treatment period.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03797677 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.